Shilo S, Slotki I N, Iaina A
Department of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel.
Isr J Med Sci. 1987 Jul;23(7):821-4.
Nine patients, six men and three women, 40 to 73 years of age, were included in the study. All of the patients had severe heart failure refractory to aggressive therapy including digitalis, diuretics, and vasodilators. Eight patients underwent one treatment of peritoneal dialysis while the remaining patient received two dialyses. The urine output was measured by an indwelling catheter; glomerular filtration rate (GFR) was determined by creatinine and inulin clearance, and renal blood flow (RBF) was determined by sodium paraamino hippurate (PAH) clearance. Following one peritoneal dialysis, the mean fluid loss/patient was 3,995 ml (range 3,200 to 5,100 ml). Dialysis was generally well tolerated. One patient, who had underlying hepatic cirrhosis and underwent two dialyses, developed hepatic failure and died 10 days after the second dialysis. At postmortem, peritonitis was discovered. All of the patients showed a marked subjective and objective clinical improvement. The mean plasma urea decreased from 154 to 71 mg/dl (P less than 0.005), and mean plasma creatinine decreased from 1.83 to 1.13 mg/dl (P less than 0.005). Blood pH was 7.30 before dialysis and increased to 7.37 (P less than 0.0125) after treatment. Mean urine output predialysis was 955 ml and increased to 1,472 ml post dialysis (P less than 0.0005). Creatinine clearance increased from 35 to 73 ml/min (P less than 0.0005). The mean inulin clearance increased from 33 ml/min predialysis to 69 ml/min post dialysis (P less than 0.0005), and mean PAH clearance increased from 96.7 to 362.5 ml/min (P less than 0.0005). Acute peritoneal dialysis is a safe and effective means for removing large quantities of excess fluid from patients with intractable heart failure.
本研究纳入了9名患者,其中6名男性,3名女性,年龄在40至73岁之间。所有患者均患有严重心力衰竭,对包括洋地黄、利尿剂和血管扩张剂在内的积极治疗无效。8名患者接受了一次腹膜透析治疗,其余1名患者接受了两次透析。尿量通过留置导管测量;肾小球滤过率(GFR)通过肌酐和菊粉清除率测定,肾血流量(RBF)通过对氨基马尿酸钠(PAH)清除率测定。一次腹膜透析后,每位患者的平均液体丢失量为3995毫升(范围为3200至5100毫升)。透析一般耐受性良好。1名患有潜在肝硬化且接受了两次透析的患者,在第二次透析后10天出现肝衰竭并死亡。尸检时发现有腹膜炎。所有患者在主观和客观临床方面均有明显改善。血浆尿素平均水平从154毫克/分升降至71毫克/分升(P<0.005),血浆肌酐平均水平从1.83毫克/分升降至1.13毫克/分升(P<0.005)。透析前血液pH值为7.30,治疗后升至7.37(P<0.0125)。透析前平均尿量为955毫升,透析后增至1472毫升(P<0.0005)。肌酐清除率从35毫升/分钟增至73毫升/分钟(P<0.0005)。菊粉清除率平均水平从透析前的33毫升/分钟增至透析后的69毫升/分钟(P<0.0005),PAH清除率平均水平从96.7毫升/分钟增至362.5毫升/分钟(P<0.0005)。急性腹膜透析是一种从顽固性心力衰竭患者体内清除大量多余液体的安全有效方法。